Fadi Abdel

Fadi Abdel, PhD, brings to the Alto team nearly three decades of industry experience leading global strategy of clinical operations, technology, and innovation, and successfully bringing decentralized and virtual trials to life. Prior to Alto, Fadi was instrumental in leading a team at Janssen R&D within the neuroscience therapeutic area, where he was driven by the mission of designing and transforming the patient experience in clinical trials utilizing human-centered design methodologies, digital health technology and data science. Fadi is also recognized as a champion of diversity, equity, and inclusion, which he sees as critical to insight, innovation, and business success. Before his tenure at Janssen, Fadi held leadership roles at Novartis and Sandoz Pharmaceuticals. Fadi received a bachelor’s degree in molecular biology from David Lipscomb University and a PhD in epidemiology from the American Military University while also studying medicine with a focus in urology at Vanderbilt University School of Medicine.